Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Julia Harwardt, Silke Pudewell, Kristina Keil, Britta Lipinski, Laura Unmuth, Thi Hong Hue Tran, Enrico Guarnera, Desislava Elter, Lukas Pekar, Doreen Manuela Floss, Monica L. Fernández‐Quintero, Andreas Evers, Stefan Zielonka
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local citing links have been materialized yet.
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
10.1038/s41577-018-0066-7 · 2018
Historical overview of the interleukin-6 family cytokine
2020
Exploring the landscape of synthetic IL ‐6‐type cytokines
10.1111/febs.16909 · 2024
Leukemia inhibitory factor (LIF)
10.1016/j.cytogfr.2015.07.001 · 2015
Leukemia inhibitory factor, a double-edged sword with therapeutic implications in human diseases
10.1016/j.ymthe.2022.12.016 · 2023
Leukemia Inhibitory Factor: An Important Cytokine in Pathologies and Cancer
10.3390/biom12020217 · 2022
Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF)
10.1002/j.1460-2075.1987.tb02742.x · 1987
Leukemia Inhibitory Factor Can Substitute for Nidatory Estrogen and Is Essential to Inducing a Receptive Uterus for Implantation But Is Not Essential for Subsequent Embryogenesis1
10.1210/endo.141.12.7855 · 2000
Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor
10.1038/359076a0 · 1992
Dysregulation of EGF Family of Growth Factors and COX-2 in the Uterus during the Preattachment and Attachment Reactions of the Blastocyst with the Luminal Epithelium Correlates with Implantation Failure in LIF- Deficient Mice
10.1210/mend.14.8.0498 · 2000
Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells
10.1038/336684a0 · 1988
Cytokines affecting survival and differentiation of an astrocyte progenitor cell line
10.1016/0165-3806(93)90132-t · 1993
Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro
10.1242/dev.120.1.143 · 1994
Astrocyte‐specific activation of TNFR2 promotes oligodendrocyte maturation by secretion of leukemia inhibitory factor
10.1002/glia.22605 · 2014
The role of the leukemia inhibitory factor receptor in neuroprotective signaling
10.1016/j.pharmthera.2017.08.008 · 2018
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells
10.1182/blood-2007-02-072587 · 2007
Leukemia inhibitory factor (LIF) modulates the development of dendritic cells in a dual manner
10.1080/08923973.2019.1619761 · 2019
Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6
10.4161/cc.8.9.8348 · 2009
Emerging Perspectives on Leukemia Inhibitory Factor and its Receptor in Cancer
10.3389/fonc.2021.693724 · 2021
The Pleiotropic role, functions and targeted therapies of LIF/LIFR axis in cancer: Old spectacles with new insights
10.1016/j.bbcan.2022.188737 · 2022
Targeting LIF/LIFR signaling in cancer
10.1016/j.gendis.2021.04.003 · 2022
Convergent Mechanisms for Recognition of Divergent Cytokines by the Shared Signaling Receptor gp130
10.1016/s1097-2765(03)00365-4 · 2003
An unusual cytokine:Ig-domain interaction revealed in the crystal structure of leukemia inhibitory factor (LIF) in complex with the LIF receptor
10.1073/pnas.0705577104 · 2007
Structural Organization of a Full-Length gp130/LIF-R Cytokine Receptor Transmembrane Complex
10.1016/j.molcel.2008.08.011 · 2008
Antibody display technologies: selecting the cream of the crop
10.1515/hsz-2020-0377 · 2022
Targeting the major pro-inflammatory interleukin-6-type cytokine receptor gp130 by antagonistic single domain antibodies
10.3389/fimmu.2025.1613004 · 2025
Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange
10.1073/pnas.1220145110 · 2013
Beyond bispecificity: Controlled Fab arm exchange for the generation of antibodies with multiple specificities
10.1080/19420862.2021.2018960 · 2022
A Generic Approach for Miniaturized Unbiased High-Throughput Screens of Bispecific Antibodies and Biparatopic Antibody–Drug Conjugates
10.3390/ijms25042097 · 2024
UCSF ChimeraX : Tools for structure building and analysis
10.1002/pro.4792 · 2023
(Cindy). JAK-STAT3 and somatic cell reprogramming
10.4161/jkst.24935 · 2013
A Unique Loop Structure in Oncostatin M Determines Binding Affinity toward Oncostatin M Receptor and Leukemia Inhibitory Factor Receptor
10.1074/jbc.m112.387324 · 2012
Structures of complete extracellular assemblies of type I and type II Oncostatin M receptor complexes
10.1038/s41467-024-54124-1 · 2024
Biophysical and biochemical characterization of a VHH-based IgG-like bi- and trispecific antibody platform
10.1080/19420862.2020.1812210 · 2020
SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies
10.1093/protein/gzp094 · 2010
Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes
10.1016/s0021-9258(17)37590-7 · 1994
Leukemia inhibitory factor induces the 85-kDa cytosolic phospholipase A2 gene expression in cultured human bronchial epithelial cells
10.1016/s0167-4889(96)00122-x · 1997
Molecular dynamics simulations reveal key roles of the LIF receptor in the assembly of human LIF signaling complex
10.1016/j.csbj.2025.01.014 · 2025
Emerging principles of cytokine pharmacology and therapeutics
10.1038/s41573-022-00557-6 · 2023
Cytokines in clinical cancer immunotherapy
10.1038/s41416-018-0328-y · 2019
Features and development of Coot
10.1107/s0907444910007493 · doi-reference
Relaxation of backbone bond geometry improves protein energy landscape modeling
10.1002/pro.2389 · doi-reference
A Pareto-Optimal Refinement Method for Protein Design Scaffolds
10.1371/journal.pone.0059004 · doi-reference
UCSF ChimeraX : Structure visualization for researchers, educators, and developers
10.1002/pro.3943 · doi-reference
Structural insights into the assembly of gp130 family cytokine signaling complexes
10.1126/sciadv.ade4395 · doi-reference
Accurate structure prediction of biomolecular interactions with AlphaFold 3
10.1038/s41586-024-07487-w · doi-reference
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
10.1038/nmeth.4169 · doi-reference
10.1007/978-1-4939-9853-1_10
10.1007/978-1-4939-9853-1_10 · doi-reference
Antigen-directed single domain antibody-based TNFR1 agonists elicit preferential killing of HER2-overexpressing cancer cells
10.1016/j.isci.2026.115327 · doi-reference
Multifunctional antibody-derived IL-12 mimetics: prospects of future clinical development
10.1080/13543784.2026.2613289 · doi-reference
Taming interleukin‐12: Engineering of bispecific antibody‐based IL ‐12 mimetics with biased agonism capacities
10.1002/pro.70072 · doi-reference
Taming the beast: engineering strategies and biomedical potential of antibody-based cytokine mimetics
10.1080/14712598.2024.2322062 · doi-reference
From discovery to the clinic: structural insights, engineering options, clinical, and ‘next wave’ applications of camelid-derived single-domain antibodies
10.1080/19420862.2025.2583210 · doi-reference
NKp46 ‐specific single domain antibodies enable facile engineering of various potent NK cell engager formats
10.1002/pro.4593 · doi-reference
Nanobody Engineering: Toward Next Generation Immunotherapies and Immunoimaging of Cancer
10.3390/antib8010013 · doi-reference
Generation and engineering of potent single domain antibody-based bispecific IL-18 mimetics resistant to IL-18BP decoy receptor inhibition
10.1080/19420862.2023.2236265 · doi-reference
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
10.1126/science.aav7532 · doi-reference
Tuning Cytokine Receptor Signaling by Re-orienting Dimer Geometry with Surrogate Ligands
10.1016/j.cell.2015.02.011 · doi-reference
Anti-drug antibodies
10.4081/dts.2012.e11 · doi-reference
Leukemia inhibitory factor: Recent advances and implications in biotechnology
10.1016/j.cytogfr.2019.11.005 · doi-reference
Engineering Strategies for Immunomodulatory Cytokine Therapies: Challenges and Clinical Progress
10.1002/adtp.202100035 · doi-reference
Next-generation cytokines for cancer immunotherapy
10.1093/abt/tbab014 · doi-reference